Skip to main content
PLOS One logoLink to PLOS One
. 2024 Apr 29;19(4):e0302481. doi: 10.1371/journal.pone.0302481

Efficacy of inverted inner limiting membrane flap technique for macular holes of ≤400 μm: A systematic review and meta-analysis

Seung Min Lee 1,2, Ji Woong Lee 2,3, Ji Eun Lee 1,2, Hee-young Choi 2,3, Jong Soo Lee 2,3, Iksoo Byon 2,3,*
Editor: Koichi Nishitsuka4
PMCID: PMC11057726  PMID: 38683767

Abstract

Purpose

To evaluate the efficacy of inverted internal limiting membrane (ILM) flap technique in full-thickness macular holes (MHs) with a size of ≤400 μm compared to the ILM peeling technique.

Methods

Related literatures that compared inverted ILM flap and ILM peeling in MHs ≤ 400 μm were reviewed by searching electronic databases including Pubmed, EMbase, ClinicalTrials.gov, and Cochrane Library up to April 2023. The primary outcome measure was hole closure rate, and the secondary outcome measures were the mean postoperative best-corrected visual acuity (BCVA), retinal sensitivity, and outer status of the retinal layers, including the external limiting membrane and ellipsoid zone. The quality of the articles was assessed according to the revised version of the Cochrane risk-of-bias tool for randomized trials or the Newcastle–Ottawa scale. In the case of heterogeneity, a sensitivity analysis was conducted, and publication bias was visually evaluated using a funnel plot.

Results

This review included six studies with 610 eyes for the primary outcome and 385 eyes for the secondary outcomes, which were two randomized control trials and four retrospective studies. Pooled data revealed that the overall MH closure rate was 99.4% in the inverted ILM flap group and 96.2% in the ILM peeling group, without significant difference between the two groups (odds ratio = 3.91; 95% confidence interval, 0.82~18.69; P = 0.09). The inverted ILM flap technique did not have a favorable effect on the BCVA, retinal sensitivity, or recovery of the outer retinal layers. These results were consistent with those of the subgroup analysis of the different follow-up periods. No significant publication bias was observed.

Conclusion

In eyes with MHs of ≤400 μm, both techniques demonstrated excellent surgical outcomes without significant differences. Therefore, surgical techniques can be selected according to surgeon preferences.

Introduction

A macular hole (MH) is a full-thickness retinal defect of the fovea, and surgical repair requires improvements in the foveal structure and visual acuity [1]. Since Eckardt et al. introduced the internal limiting membrane (ILM) peeling (ILMP) technique, which leads to successful hole closure of approximately 90% in primary surgery [24]. However, such a high success rate is not achieved in chronic large MHs (>400 μm) [57]. Therefore, various techniques, including autologous concentrated platelets and autologous serum, have been applied, although they are not widely accepted owing to conflicting outcomes in the treatment of large MHs [8,9].

In 2010, Michalewska et al. reported an innovative surgical technique using an inverted ILM flap (ILMF) with a high closure rate for large MHs [5]. Many clinical studies and meta-analyses have confirmed that the ILMF technique is superior to the ILMP technique for hole closure and visual recovery in complicated large MHs, including myopic MH and MH retinal detachment [6,7,10,11]. However, considering the surgical procedure, the ILMF technique requires more effort to stabilize, which is a potential difficulty in performing this technique. In cases of inserted ILMF inside the hole, visual and anatomical recovery can be limited [1214]

Regarding excellent surgical outcomes of ILMP for the treatment of small- and medium-sized MHs (≤400 μm), selecting between ILMP and ILMF as the primary surgical procedure is controversial [1416]. In addition, a paucity of literature, insufficient sample sizes, and inadequate levels of evidence for comparison studies between the two surgical procedures limit our understanding [1722].

Therefore, we conducted a meta-analysis of all available randomized control trials and other comparative studies to evaluate the efficacy of the ILMF technique compared to the ILMP technique for MHs of ≤400 μm in diameter.

Materials and methods

Search strategy

We comprehensively searched for relevant literature in electronic databases, including PubMed, Embase, ClinicalTrials.gov, and Cochrane Library until April 10, 2023. The terms used for systematic search were as follows: ("macular hole" OR "MH") AND ("inverted flap" OR "Internal limiting membrane flap" OR "inner limiting membrane flap" OR "ILM flap") AND ("small" OR "medium"). This meta-analysis was conducted according to the Cochrane Handbook for Systematic Reviews of Interventions version 6.3 and the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) Statement [23,24, S1 Checklist]. No restrictions on language and publication year were applied when searching the electronic databases. The search results were imported into the reference management software (EndNote 20, Thomson Reuters, New York, NY, USA), and duplicate titles were removed from the merged list of literature. The titles and abstracts were checked to exclude irrelevant studies, and the full texts of the relevant literature were checked to confirm whether they satisfied the inclusion and exclusion criteria. In addition to the reviewed articles, their reference lists were explored as additional eligible sources.

Inclusion and exclusion criteria

We used the following inclusion criteria according to population, intervention, comparison, outcomes, and study design protocol.

First, for population (participants), patients diagnosed with idiopathic full-thickness MH and a minimum linear diameter of the MH ≤ 400 μm according to the International Vitreomacular Traction Study Group classification and followed up for >1 month after the procedure were included in the present study [25].

Second, for intervention, ILMF with the ILMP technique in the experimental group and the ILMP-only technique in the control group were compared. No limitations on the flab stabilizer, gauge of the vitrectomy system, and combination of phacoemulsification or tamponade except silicone oil were applied.

Third, for outcome measures, the primary outcome measure was anatomical hole closure rate in the first operation. Type 1 MH closure should be confirmed using optical coherence tomography (OCT) described by Kang et al. [26]. The secondary outcome measures were visual function and recovery of the outer retinal layers. Visual function was evaluated using the best-corrected visual acuity (BCVA) and retinal sensitivity. BCVA was converted to the logarithm of the minimum angle of resolution. The BCVA before surgery and 3, 6, and 12 months after surgery were compared. Retinal sensitivity measured by microperimetry in the central 8°–10° was used for the analysis. Recovery of the outer retinal layers was defined as a continuous line of the external limiting membrane (ELM) or ellipsoid zone as confirmed using OCT. One or more outcomes were reported in each selected study.

Lastly, prospective randomized controlled trials (RCTs), prospective non-RCT studies, and retrospective comparative studies were included.

The exclusion criteria were as follows: MHs with complications, including severe cataracts hindering retinal measurement, glaucoma, degenerative myopia, retinal detachment, ocular inflammation secondary to vitrectomy, and trauma; data required for this meta-analysis were not provided or not available to yield outcomes; poor-quality literature; duplicate publication using the same materials; and care reports, case series without comparative data, surgical techniques, or review articles.

Data extraction

The literature was reviewed, and data were independently extracted by two investigators (S.M.L and I.B.). Any discrepancies in the literature selection and data extraction were resolved via discussion with a third researcher or consultation with an expert. The extracted data included the following: first author, year of publication, country, study design, sample size of each group, mean age, MH size, MH closure rate, preoperative BCVA, postoperative BCVA at 3, 6, and 12 months, retinal sensitivity, and recovery rate of the EZ and ELM.

Qualitative assessment

The quality of the selected RCT was evaluated using the revised version of the Cochrane risk of bias tool for randomized trials (RoB2) [24]. Bias was evaluated by subdividing it into five domains: (1) the randomization process, (2) deviations from intended interventions, (3) missing outcome data, (4) outcome measurement, and (5) selection of the reported result. Each domain was assigned a "low risk of bias,” "some concerns,” or “high risk of bias.” The overall results for each domain are presented according to the RoB2 process.

The methodological quality of non-randomized studies, including prospective and retrospective case–control studies, was assessed using the Newcastle–Ottawa scale (NOS) [27]. Each study rated in three categories including "selection,” "comparability” and "exposure.” A study can award one star for each item in selection and exposure, and earn up to two stars for comparability. In this study, the quality of the study was defined as low, moderate, and high according to the NOS scores of 0–3, 4–6, and 7–9, respectively. All items were independently evaluated by two researchers (S.M.L and I.B.), and assessment discordance was resolved through discussion or expert consultation.

Statistical analysis

Data were statistically analyzed using Review Manager 5.30 (Cochrane Collaboration, Oxford, UK). To analyze dichotomous variables, including rate of MH closure and recovery of ELM and EZ, the Mantel–Haenszel (M–H) method was used, and results were presented as odds ratios (OR) and 95% confidence intervals (CI). For analysis of continuous variables, including BCVA and retinal sensitivity, the weighted mean difference (WMD) with 95% CI was calculated using the inverse-variance approach. Statistical significance was defined as P < 0.05. Significant heterogeneity was defined characterized by a statistically significant result of the χ2 test (P <0.1) or a >50% result in Higgin’s I2 statics [28]. A random-effects model was used for cases with significant heterogeneity, whereas a fixed-effects model was used when no significant heterogeneity is observed [29]. To verify the robustness and credibility of the results in this meta-analysis, a sensitivity analysis was conducted by removing the included studies individually until the source of heterogeneity was identified, resulting in resolving significant heterogeneity after removal. Subgroup analysis was also used to perform a sensitivity analysis. Owing to the limited number of included studies, evaluation of publication biases by subgroup analysis and asymmetry assessment of the funnel plot were not conducted, and funnel plots were presented to visualize the evaluation for publication bias.

We merged data that were originally divided into subgroups in the form of mean values and standard deviations in accordance with the formula in Chapter 6 of the Cochrane Handbook [24]. When the standard deviation was not presented, we used the formula in the Cochrane Handbook and the method of Wan et al. to obtain the standard deviation from the range or interquartile ranges [24,30].

Results

Study selection

In total, 356 studies were identified through the database searches. Among these, 82 duplicates were removed, and 262 records of the remaining 274 articles were excluded after a preliminary review by checking the titles and abstracts for irrelevant topics, non-comparative studies, reviews, surgical techniques, and duplicated results of RCTs due to publication. A total of 12 studies were retrieved for full-text review, although2 studies were discarded, as one RCT had no results, and the other had no full text available. Among the remaining 10 eligible studies, four studies, including one article with different surgical techniques and three articles without MH size categorization, were excluded after reading and evaluating the full text. Six studies met the inclusion criteria. Two studies were RCTs, and four were retrospective case–control studies [1722]. Fig 1 illustrates the study selection process.

Fig 1. Flow diagram of the literature screening process according to the PRISMA-p guideline.

Fig 1

Quality assessment

The quality of the two RCTs was assessed in accordance with the ROB2 and is summarized in Fig 2 [25,26].

Fig 2. Assessment of the risk of bias in included randomized controlled trials according to the revised version of Cochrane risk-of-bias tool for randomized trials.

Fig 2

In two studies, overall assessment was identified as low risk.

Both the studies had a low overall risk of selection bias. In the retrospective case–control studies, four studies were evaluated using the NOS scale, and all studies fulfilled the high-quality criteria with overall 7 to 9 stars [1719,22] The qualitative assessment of the case–control studies is presented in Table 1.

Table 1. Quality assessment using the Newcastle–Ottawa scale for non-randomized controlled trial studies.

Author Selection Comparability Outcome Total score
1 2 3 4 1 2 3
Baumann et al. 2021 [17] ☆☆ 9
Chou et al. 2021 [18] ☆☆ 8
Iuliano et al. 2023 [19] ☆☆ 7
Yamada et al. 2022 [22] ☆☆ 8

Selection 1: Adequate case definition.

Selection 2: Representativeness of the cases.

Selection 3: Selection of controls.

Selection 4: Definition of controls.

Comparability 1: Comparison of cases and controls based on the design or analysis.

Outcome 1: Assessment of exposure.

Outcome 2: Same method of ascertainment for cases and controls.

Outcome 3: Nonresponse rate.

Study characteristics

These studies were published between 2021 and 2023. Two studies were conducted in Italy [19,21], one in Japan [22], one in Taiwan [18], one in Austria [20], and one each in Germany and the United Kingdom [17]. The characteristics of the included studies are summarized in Table 2.

Table 2. Characteristics of studies included in the meta-analysis: Baseline characteristics of the inverted internal limiting membrane flap and internal limiting membrane peeling groups.

First author, Year Study design Country Tamponade Dye Flap
insertion
Group No. of eyes Mean age
(years)(SD)
Baseline MH
size(μm)
Hole closure
rate
Preoperative
BCVA
(logMAR)
Postoperative
BCVA
(logMAR)
Follow-up
time (months)
Baumann et al., [17]
2021
Non-RCT Germany, UK SF6, C2F2, or C3F8 BBG
± TP
Covering ILMF 24 63.1 ± 7.7 282 ± 104 100% (68/68) 0.77 ± 0.32 0.18 ± 0.12 12
2017–2019 ILMP 36 70.5 ± 8.2 236 ± 86 96% (296/308) 0.74 ± 0.30 0.26 ± 0.20
Chou et al.,[18]
2021
Non-RCT Taiwan SF6 or C3F8 ICG Covering ILMF 55 61.3 ± 6.4 251.9 ± 76.7 98% (54/55) 1.05 ± 0.43 0.48 ± 0.33 1~12
2012–2020 ILMP 62 58.8 ± 9.9 261.6 ± 99.7 97% (60/62) 1.05 ± 0.36 0.51 ± 0.36
Iuliano et al.,[19]
2023
Non-RCT Italy SF6 Bluelife
and TP
Covering ILMF 50 69.8 ± 11.3 237.9 ± 39.2 NA 0.67 ± 0.13 0.16 ± 0.11 6
2014–2021 ILMP 50 70.6 ± 10.1 242.0 ± 33.9 NA 0.68 ± 0.15 0.12 ± 0.10
Lesisser et al.,[20]
2023
RCT Austria SF6 BBG
and TP
Covering ILMF 7 71 ± 7 275 ± 90 100% (7/7) 0.70 ± 0.11 0.30 ± 0.14 3
2018–2021 ILMP 9 67 ± 5 244 ± 101 100% (9/9) 0.76 ± 0.26 0.34 ± 0.10
Ventre et al.,[21]
2022
RCT Italy SF6 BBG
and TP
Covering ILMF 25 62 ± 5 269 ± 52 100% (25/25) 0.76 ± 0.22 0.22 ± 0.11 12
2020 ILMP 25 64 ± 5 254 ± 70 100% (25/25) 0.72 ± 0.21 0.19 ± 0.14
Yamada et al.,[22]
2022
Non-RCT Japan SF6 NA Covering
or filling
ILMF 21 66.2 ± 10.6 278.6 ± 80.7 100% (21/21) 0.71 ± 0.3 0.28 ± 0.24 12
2014–2017 ILMP 21 66.6 ± 7.0 276.0 ± 84.5 90% (19/21) 0.73 ± 0.3 0.24 ± 0.24

Abbreviations: BBG, brilliant blue G; BCVA, best corrected visual acuity; C2F2, perfluoroethane; C3F8, perfluoropropane; FU, follow-up; ICG, indocyanine green; ILMF, inverted internal limiting membrane flap; ILMP, internal limiting membrane peeling; RCT, randomized controlled trial; logMAR, logarithm of the minimum angle of resolution; MH, macular hole; NA, not available for statistics; No, number; SD, standard deviation; SF6, sulfur hexafluoride; TP, Trypan blue; UK, United Kingdom.

Since Chou et al. documented additional data for the MH closure rate [17], the number of eyes included in this meta-analysis was 610 for the MH closure rate analysis and 385 for the secondary outcomes. In total, 178 eyes in the ILMF group and 432 eyes in the ILMP group for MH closure and 182 eyes in the ILMF group and 203 eyes in the ILMP group for the secondary outcomes were analyzed. The sample sizes of the included studies ranged from 16 to 117. The mean age of the patients ranged from 58 to 71 years. The vital dyes used for ILM staining were brilliant blue G and/or trypan blue in three studies [17,18,21], blue life and trypan blue in one study [19], indocyanine green in one study [18], and unknown in one study [22]. Gas tamponade was used at the end of the surgery in all studies, and the face-down posture was maintained for 1–7 days. The follow-up duration was >1 month in one study [18], 3 months in one study [20], 6 months in one study [19], and 12 months in three studies [17,21,22].

MH closure

MH closure (primary outcome measure) was achieved in 177 of 178 eyes (99.4%) in the ILMF group and in 407 of 423 (96.2%) eyes in the ILMP group. In the study by Iuliano et al., as unclosed MH were not included, they were excluded from MH closure rate assessment. The combined result of five studies revealed no significant difference in MH closure rate between the ILMF and ILMP groups in OR comparison (OR = 3.91; 95% CI, 0.82 to 18.69; P = 0.09), with no heterogeneity (P = 0.77 in χ2 test, I2 = 0%) (Fig 3).

Fig 3. Forest plot of comparison of macular hole closure rate between the inverted internal limiting membrane flap and internal limiting membrane peeling groups.

Fig 3

No significant difference was observed between two groups. A fixed-effects model was used with no heterogeneity. CL, confidence interval; ILM, internal limiting membrane; M–H, Mantel–Haenszel.

In order to exclude the effect of the additional data for MH closure described by Chou et al., when the MH closure rate of the two groups was compared without result of Chou et al., no significant difference in the results was observed (OR = 5.68; 95% CI, 0.67~47.91; P = 0.11).

Visual acuity recovery

Data from six studies were used to assess the preoperative and postoperative BCVA. The preoperative BCVA was 0.72 ± 0.30 with the ILMF group and 0.74 ± 0.28 with the ILMP group. No significant difference in baseline BCVA was observed between the ILMF and ILMP groups (WMD, 0.00; 95% CI, −0.04 to 0.05; P = 0.89) (Fig 4).

Fig 4. Forest plots of comparison of postoperative best-corrected visual acuity (BCVA) between the inverted internal limiting membrane flap and internal limiting membrane peeling groups.

Fig 4

(A) Forest plot of postoperative BCVA and (B)–(D) forest plots of postoperative BCVA based on the follow-up duration as the subgroup analysis. The subgroup analysis compared BCVA between two groups at (B) 3 months, (C) 6 months, and (D) 12 months postoperatively, respectively, and no differences were identified. A random-effects model was used in the analysis at 3 months and 6 months since significant heterogeneity was observed. CL, confidence interval; ILM, internal limiting membrane; IV, inverse variance; SD, standard deviation.

The postoperative BCVA of six studies were used to compare the differences between the ILMF and ILMP groups. The postoperative BCVA was 0.20 ± 0.20 in the ILMF group and 0.18 ± 0.24 in the ILMP group, without significant difference between the two groups (WMD, 0.01; 95% CI, −0.02 to 0.04; P = 0.37). Because of no substantial heterogeneity (P = 0.15, I2 = 38%), a fixed-effects model was used. A sensitivity analysis was performed, and heterogeneity was eliminated after removing the result of Baumann et al. However, it did not alter the result (WMD, 0.03; 95% CI, −0.00 to 0.06; P = 0.08).

A subgroup analysis based on follow-up duration was performed to eliminate the effects of different follow-up times. The data for postoperative BCVA at 3, 6, and 12 months were available in three, three, and four articles, respectively. The meta-analysis demonstrated no significant benefits of the ILMF technique over the ILMP technique in visual recovery over 12 months of observation (Fig 4). The WMD (95% CI) of BCVA between both groups at 3, 6, and 12 months were −0.06 (−0.24 to 0.12), 0.00 (−0.11 to 0.12), and −0.01 (−0.06 to 0.03), respectively. Owing to heterogeneity of pooled data at 3 months and 6 months (P = 0.008; I2 = 79%, P = 0.004; I2 = 70%), a random-effects model was used to analyze the 3 months and 6 months results.

Retinal sensitivity

Two studies which conducted retinal sensitivity test and compared retinal sensitivity between the ILMF and ILMP groups identified no significant difference in preoperative and postoperative values between the two groups without heterogeneity (WMD, 0.29 and −0.81; 95% CI, −0.46–1.04 and −2.14–0.51; P = 0.45 and 0.23) (Fig 5).

Fig 5. Forest plots of comparison of retinal sensitivity between the inverted internal limiting membrane flap and internal limiting membrane peeling groups.

Fig 5

No significant difference was observed between two groups. Owing to significant heterogeneity, a random-effects model was used. CL, confidence interval; ILM, internal limiting membrane; IV, inverse variance; SD, standard deviation.

Since postoperative examinations of retinal sensitivity were performed at different times, at 6 months and 12 months postoperatively, respectively, in the two studies, and heterogeneity was observed, a random-effects model was used (P = 0.06, I2 = 71%). A sensitivity analysis could not be performed because only two studies were related.

Outer retinal anatomical recovery

The postoperative recovery of ELM was compared between the ILMF and ILMP groups in four studies. Complete recovery of ELM did not differ between two groups (WMD, 0.83; 95% CI, 0.44–1.55; P = 0.56), and no significant heterogeneity was observed. When the subgroup analysis was performed regarding the follow-up period, ELM recovery was observed in 82% (range: 62%–93%) and 77% (range: 75%–80%) at 3 months, 61% (range: 42%–95%) and 68% (range: 50%–88%) at 6 months, and 92% (range: 72%–100%) and 91% (range: 85%–96%) at 12 months in the ILMF group and ILMP groups, respectively. No significant difference in the meta-analysis was observed between the two groups (Fig 6).

Fig 6. Forest plots of comparison of complete recovery rate of external limiting membrane between the inverted internal limiting membrane flap and internal limiting membrane peeling groups.

Fig 6

(A) Comparison of external limiting membrane recovery after surgery and (B)–(D) the result of subgroup analysis based on follow-up duration. The follow-up duration was subdivided into (B) 3 months, (C) 6 months, and (D) 12 months after surgery, and no significant difference at each period was observed between the two groups. A random-effects model was used in the analysis in the 3-month and 12-month results since a significant heterogeneity was observed. CL, confidence interval; ILM, internal limiting membrane; M–H, Mantel–Haenszel.

As heterogeneity was observed in the 3-month and 12-month data, a random-effects model was used (P = 0.03, I2 = 70%; P = 0.12, I2 = 53%). Because the available data were from one study with 3-month and 12-month data, one study with only 6-month data, and two studies with all follow-up data in the subgroup analysis, the number of studies in the pooled data for each follow-up period was three.

EZ was completely recovered in 28% (range, 9%–43%) and 27% (range, 8%–48%) at 3 months and 47% (range, 40%–52%) and 52% (range, 44%–64%) at 6 months in the ILMF and ILMP groups, respectively. No significant difference in postoperative EZ recovery was observed between the two groups without heterogeneity (Fig 7).

Fig 7. Forest plots of comparison of complete recovery rate of ellipsoid zone between the inverted internal limiting membrane flap and internal limiting membrane peeling groups.

Fig 7

Comparison of ellipsoidal zone recovery at (A) 3 months and (B) 6 months after surgery revealed no significant difference between the two groups. CL, confidence interval; ILM, internal limiting membrane; M–H, Mantel–Haenszel.

Available data were obtained from one study with 3-month data, one study with 6-month data, and two articles with follow-up data. In the subgroup analysis, three studies were included in the pooled data for each follow-up period. Recovery of the EZ status at 12 months was not analyzed because of the small number of patients included.

Publication bias analysis

Funnel plots for publication bias assessment of the MH closure rate, preoperative and postoperative BCVA, and ELM recovery are presented in Fig 8.

Fig 8. Funnel plot for evaluating the publication bias.

Fig 8

(A) Macular hole closure rate; (B) preoperative best-corrected visual acuity (BCVA); (C) postoperative BCVA; (D) complete recovery rate of external limiting membrane. (A)–(D) Scattered points corresponding to the included studies were mostly distributed within the range of inverted funnel. (C) One point of study in postoperative BCVA was located slightly out of the inverted funnel. A relatively low publication bias could have influenced the results. OR, odds ratio; MD, mean difference; SE, standard error.

Data on the MH closure rate in the included studies revealed scattered points distributed in the middle of the inverted funnel. In the pre- and postoperative BCVA, scattered points were distributed near the mean value of the mean difference. In the funnel plot of the ELM recovery rate, positions for studies with small sample sizes or lower mean values appeared vacant. Because all studies were located within the inverted funnel range except for the study by Baumann et al., in which postoperative BCVA was located slightly outside the funnel shape, publication bias in postoperative BCVA was a concern. However, because the results of the sensitivity analysis were not significantly different, and no evidence of publication bias for the remaining items was noted, the publication bias may be low, and the conclusion is relatively reliable.

Discussion

In the present meta-analysis, six literatures including two RCTs with low risk-of-bias and four retrospective studies with high-quality comparing ILMF technique and ILMP technique for MH of <400 μm were reviewed. A total of 610 eyes were included in the comparison of MH closure rate (178 eyes in the ILMF group and 432 eyes in the ILMP group), and 385 eyes were included in the secondary outcome measures (182 eyes in the ILMF group and 203 eyes in the ILMP group). In the results of the primary outcome measure, the MH closure rate, the analysis of integrated data revealed no more favorable results of the ILMF technique over ILMP technique for MH closure, as both techniques demonstrated excellent success rates of 99.4% in the ILMF group and 96.2% in the ILMP group, respectively. For secondary outcome measures, including the recovery of visual acuity, retinal sensitivity, and recovery of the EZ and ELM, no significant differences were observed between the two groups. No favorable technique was identified in the subgroup analyses for the recovery of visual acuity and outer retinal structure at each follow-up period.

Considering that the main cause of idiopathic MH is anteroposterior and tangential traction, vitrectomy to release vitreous traction and gas tamponade is effective for hole closure. The success rate of surgery has been reported as 69%–78% [1,8,31,32]. Additionally, the ILMP technique was introduced to achieve complete traction removal around the hole. It increases the hole closure rate up to approximately ≥90% by reducing of retinal stiffness, removing residual vitreous cortex, and stimulating retinal glial proliferation after ILM removal [31,3336]. Despite the introduction of the ILMP technique, refractory MHs, including large and myopic MH, present with low closure rates, even when additional procedures are applied [5,37,38]. ILMF techniques, initially introduced for large MH, have demonstrated high closure rates in various refractory MH surgeries [5,6,37,39]. Meta-analyses have demonstrated that the ILMF technique has a significant advantage over the ILMP technique for large MH [10,40]. The success rate can be explained as follows. The ILM flap acts as a scaffold for glial cell proliferation, a source of neurotrophic and growth factors, and a barrier to turbulent flow by covering the hole [39,41,42].

Regarding the high closing rate of large MH, the ILMF technique has been introduced for small- to medium-sized MHs. However, whether ILMF is superior to ILMP, particularly in terms of visual outcomes, is unclear [11,1522]. In terms of surgical preference, the ILMP technique is relatively easier and simpler than the ILMF technique for stabilizing the flap over the hole. The ILMF technique requires more surgical time and skill to create and stabilize the flap, which can be a potential hurdle for beginners to perform this technique. In addition, excessive glial proliferation by the ILM flap is possible following hole closure, which can limit the recovery of visual acuity and the outer retinal layer [1214]. The ILMF technique has the following advantages. The foveal contour can improve with time after the disappearance of the gas tamponade because the ILM flap over the hole acts as a lid to protect the hole and promote the recovery of retinal tissues [7,18]. In this regard, the more suitable primary surgical technique in MHs >400 μm is debatable [1416]. However, our understanding of this issue is limited because of the paucity of literature and conflicting results from a few studies comparing ILMF and ILMP techniques [1722].

Five studies were included in analyzing the closure rate in MHs <400 μm in this meta-analysis [17,18,2022]. No significant differences between the two surgical techniques. This finding was confirmed in a meta-analysis of 610 eyes. This indicated that the ILMF technique does not provide additional benefits in anatomical success of MHs of <400 μm. This can be explained as follows. ILMP have demonstrated very high closure rates ranging from 96% to 100%. Therefore, demonstrating the superiority of the ILMF technique in closing holes in small-to medium-sized MHs was difficult [1517]. MHs with a mean diameter of 312.5 ± 105.2 μm were reportedly closed 24 h postoperatively [43]. MH closure was also observed in all eyes when the sum length of both hole slopes was >90% of the base diameter of the hole, potentially with most of the holes covered by tissue [44]. This implies that tissue apposition around the hole occurs more easily and rapidly after surgery. Therefore, an ILM flap covering the holes might not be needed in small-to-medium-sized MHs.

To compare outer retinal integrity, four studies were included in the ELM analysis and three studies were included in the EZ analysis. No significant differences in outer retinal recovery were observed in our meta-analysis. In terms of recovery time, no significant difference was observed between the ELM and EZ at each follow-up visit. Two previous studies demonstrated favorable outcomes with the ILMP technique [19,22]. However, contradictory outcomes have been reported. Yamada et al. and Iuliano et al. have reported that rapid recovery of the ELM and EZ was achieved using the ILMP technique [1922]. They concluded that part of the ILM in the hole could interrupt the approximation of the outer retina, inducing delayed recovery of the ELM and EZ [19,22]. However, Chou et al. have reported that the ILMF technique was associated with faster recovery [18]. They assumed that the lack of disturbance to glial tissue formation by the ILM flap over the hole promoted rapid recovery [18]. These conflicting results may be attributed to the detailed surgical techniques, including conventional or modified ILMF techniques.

Six studies performed meta-analyses of visual outcomes [1722]. No significant differences in preoperative and postoperative visual acuity were observed between the two surgical techniques. However, sensitivity tests were applied to resolve heterogeneity because the final visual acuity indicated heterogeneity. Chou et al. have reported that the ILMF group achieved rapid visual recovery at 3 and 6 months, despite no difference in final visual acuity [18]. However, its missing data (40% and 20% in the ILMF group and 6% and 8% in the ILMP group at 3 and 6 months, respectively) limited our understanding [18]. Other studies have not reported any differences in the recovery time of visual acuity between the two techniques.

Two studies were included in this meta-analysis of retinal sensitivity. Contrary outcomes have been reported in previous studies [19,21]. Ventre et al. have reported improved retinal sensitivity in the ILMP group at 6 and 12 months [21]. They measured retinal sensitivity in the range of 8°. However, Iuiano et al. have demonstrated that the ILMP technique achieved better retinal sensitivity in the 4° range but did not demonstrate a difference in the 10° range. The meta-analysis of the two studies revealed no differences in the baseline and follow-up visits between the two surgical techniques. Based on these findings, retinal sensitivity may depend on the assessed macular area. In addition, instrumental differences may have affected the outcomes. More studies are needed to compare retinal sensitivity between the ILMF and ILMP techniques.

The present study has several limitations. First, only few studies were included. The sample size of each study was small. Second, the different follow-up periods of the studies could have influenced the surgical and visual outcomes in this analysis because the data were not sufficient to demonstrate complete recovery of visual acuity and outer retinal layers in some studies. Third, because a small number of RCTs were included despite the low bias of the included literature, data quality and selection bias could be problematic factors in the present study. Fourth, bias may be present owing to missing data. Fifth, many other factors that could affect the outcomes, such as the duration of disease, vital dyes, tamponade material, and face-down period, were not considered. Sixth, cataract surgery was performed as required in most studies. Cataract status may also influence visual outcomes. Seventh, the P value of the difference of the two techniques in MH closure rate was 0.09, which tends to be close to a significant difference. The retrospective studies may have an inherent selection bias. About half of eyes were derived from the data of Baumann and colleagues’ study (the closure rates of the ILM flap and ILM peeling technique were 100% and 96%, respectively). These might impact on the overall results of our analysis. To clarify this, when excluding the data of Baumann et al., additional meta-analysis showed that the closure rate of MH approached to 99% (109/110) in the inverted flap technique and 97% (111/115) in the ILM peeling technique, respectively (P = 0.45). This also showed no difference of two surgical techniques in the primary hole closure rate. However, different outcomes may come out if more data can be achieved in future RCT studies. Eighth, the surgeon’s factor of the inverted ILM flap technique can be more various than the ILM peeing technique and it may influence the outcomes. Lastly, in the retinal sensitivity analysis, we could not analyze sufficient data from the studies using a uniform assessment.

Conclusions

No significant differences in hole closure rate, visual prognosis, retinal sensitivity, and outer retinal recovery were observed between the ILMF and ILMP techniques for the treatment of MHs ≤400 μm. Both techniques demonstrated high success rates for hole closure and improved the visual function and outer retinal anatomy. Based on these findings, both surgical techniques can be beneficially used depending on the surgeon’s preference for small-to-medium-sized MH. For a more accurate comparison of surgical technique studies, additional RCTs with larger sample sizes and standardized surgical techniques are necessary.

Supporting information

S1 Checklist. PRISMA 2009 checklist.

(DOCX)

pone.0302481.s001.docx (28.6KB, docx)

Data Availability

All relevant data are within the paper and its Supporting information files.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Gass JDM. Reappraisal of biomicroscopic classification of stages of development of a macular hole. Am J Ophthalmol. 1995;119: 752–759. doi: 10.1016/s0002-9394(14)72781-3 [DOI] [PubMed] [Google Scholar]
  • 2.Eckardt C, Eckardt U, Groos S, Luciano L, Reale E. Entfernung der Membrana limitans interna bei Makulalöchern. Klinische und morphologische Befunde [Removal of the internal limiting membrane in macular holes. Clinical and morphological findings]. Ophthalmologe. 1997;94: 545–551. [DOI] [PubMed] [Google Scholar]
  • 3.Tognetto D, Grandin R, Sanguinetti G, Minutola D, Di Nicola M, Di Mascio R, et al. Macular Hole Surgery Study Group. Internal limiting membrane removal during macular hole surgery: results of a multicenter retrospective study. Ophthalmology. 2006;113: 1401–1410. [DOI] [PubMed] [Google Scholar]
  • 4.Lois N, Burr J, Norrie J, Vale L, Cook J, McDonald A, et al. Full-thickness Macular Hole and Internal Limiting Membrane Peeling Study (FILMS) Group. Internal limiting membrane peeling versus no peeling for idiopathic full-thickness macular hole: a pragmatic randomized controlled trial. Invest Ophthalmol Vis Sci. 2011;52: 1586–1592. doi: 10.1167/iovs.10-6287 [DOI] [PubMed] [Google Scholar]
  • 5.Michalewska Z, Michalewski J, Adelman RA, Nawrocki J. Inverted internal limiting membrane flap technique for large macular holes. Ophthalmology. 2010;117: 2018–2025. doi: 10.1016/j.ophtha.2010.02.011 [DOI] [PubMed] [Google Scholar]
  • 6.Kannan NB, Kohli P, Parida H, Adenuga OO, Ramasamy K. Comparative study of inverted internal limiting membrane (ILM) flap and ILM peeling technique in large macular holes: a randomized-control trial. BMC Ophthalmol. 2018;18: 177. doi: 10.1186/s12886-018-0826-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Pak KY, Park JY, Park SW, Byon IS, Lee JE. Efficacy of the Perfluoro-N-Octane-Assisted Single-Layered Inverted Internal Limiting Membrane Flap Technique for Large Macular Holes. Ophthalmologica. 2017;238: 133–138. doi: 10.1159/000477823 [DOI] [PubMed] [Google Scholar]
  • 8.Ezra E, Gregor ZJ. Surgery for idiopathic full-thickness macular hole: two-year results of a randomized clinical trial comparing natural history, vitrectomy, and vitrectomy plus autologous serum: Morfields Macular Hole Study Group Report no. 1. Arch Ophthalmol. 2004;122: 224–236. [DOI] [PubMed] [Google Scholar]
  • 9.Kim M, Won JY, Choi SY, Kim M, Ra H, Jee D, et al. Therapeutic Efficacy of Autologous Platelet Concentrate Injection on Macular Holes with High Myopia, Large Macular Holes, or Recurrent Macular Holes: A Multicenter Randomized Controlled Trial. J Clin Med. 2021;10:2727. doi: 10.3390/jcm10122727 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Shen Y, Lin X, Zhang L, Wu M. Comparative efficacy evaluation of inverted internal limiting membrane flap technique and internal limiting membrane peeling in large macular holes: a systematic review and meta-analysis. BMC Ophthalmol. 2020;20: 14. doi: 10.1186/s12886-019-1271-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Shu Y, Shao Y, Wang Y, Bi Y. Trends and Hotspots Concerning Macular Hole between 2002 and 2021: A 20-Year Bibliometric Study. J Pers Med. 2022;13: 75. doi: 10.3390/jpm13010075 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Lee SM, Kwon HJ, Park SW, Lee JE, Byon IS. Microstructural changes in the fovea following autologous internal limiting membrane transplantation surgery for large macular holes. Acta Ophthalmol. 2018;96: e406–e408. doi: 10.1111/aos.13504 [DOI] [PubMed] [Google Scholar]
  • 13.Park JH, Lee SM, Park SW, Lee JE, Byon IS. Comparative analysis of large macular hole surgery using an internal limiting membrane insertion versus inverted flap technique. Br J Ophthalmol. 2019;103: 245–250. doi: 10.1136/bjophthalmol-2017-311770 [DOI] [PubMed] [Google Scholar]
  • 14.Tao M, Wang G, Gou Y, Zhang M. Comparative Study of Conventional Inverted ILM Flap Covering and ILM Flap Filling Technique in Idiopathic Macular Hole Treatment: A Meta-Analysis and Systematic Review. J Ophthalmol. 2022;2022: 4922616. doi: 10.1155/2022/4922616 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Tadayoni R, Gaudric A, Haouchine B, Massin P. Relationship between macular hole size and the potential benefit of internal limiting membrane peeling. Br J Ophthalmol. 2006;90: 1239–1241. doi: 10.1136/bjo.2006.091777 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Christensen UC, Krøyer K, Sander B, Larsen M, Henning V, Villumsen J, et al. Value of internal limiting membrane peeling in surgery for idiopathic macular hole stage 2 and 3: a randomised clinical trial. Br J Ophthalmol. 2009;93: 1005–1015. doi: 10.1136/bjo.2008.151266 [DOI] [PubMed] [Google Scholar]
  • 17.Baumann C, Dervenis N, Kirchmair K, Lohmann CP, Kaye SB, Sandinha MT. FUNCTIONAL AND MORPHOLOGICAL OUTCOMES OF THE INVERTED INTERNAL LIMITING MEMBRANE FLAP TECHNIQUE IN SMALL-SIZED AND MEDIUM-SIZED MACULAR HOLES <400 μm. Retina. 2021;41: 2073–2078. [DOI] [PubMed] [Google Scholar]
  • 18.Chou HD, Liu L, Wang CT, Chen KJ, Wu WC, Hwang YS, et al. Single-Layer Inverted Internal Limiting Membrane Flap Versus Conventional Peel for Small- or Medium-Sized Full-Thickness Macular Holes. Am J Ophthalmol. 2022;235: 111–119. doi: 10.1016/j.ajo.2021.08.016 [DOI] [PubMed] [Google Scholar]
  • 19.Iuliano L, Corbelli E, Bandello F, Codenotti M. INVERTED INTERNAL LIMITING MEMBRANE FLAP FOR SMALL-SIZED (<250 μm) FULL-THICKNESS MACULAR HOLE: Anatomical and Functional Outcome. Retina. 2023;43: 547–554. [DOI] [PubMed] [Google Scholar]
  • 20.Leisser C, Ruiss M, Pilwachs C, Findl O. ILM peeling with ILM flap transposition vs. classic ILM peeling for small and medium macula holes-a prospective randomized trial. Spektrum Augenheilkd. 2023;37: 9–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Ventre L, Fallico M, Longo A, Parisi G, Russo A, Bonfiglio V, et al. CONVENTIONAL INTERNAL LIMITING MEMBRANE PEELING VERSUS INVERTED FLAP FOR SMALL-TO-MEDIUM IDIOPATHIC MACULAR HOLE: A Randomized Trial. Retina. 2022;42: 2251–2257. doi: 10.1097/IAE.0000000000003622 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Yamada K, Oishi A, Kusano M, Kinoshita H, Tsuiki E, Kitaoka T. Effect of inverted internal limiting membrane flap technique on small-medium size macular holes. Sci Rep. 2022;12:731. doi: 10.1038/s41598-021-04739-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al.; PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4: 1. doi: 10.1186/2046-4053-4-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane handbook for systematic reviews of interventions version 6.3 (updated February 2022). Cochrane. 2022. www.training.cochrane.org/handbook.
  • 25.Duker JS, Kaiser PK, Binder S, de Smet MD, Gaudric A, Reichel E, et al. The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology. 2013;120(12):2611–9. doi: 10.1016/j.ophtha.2013.07.042 [DOI] [PubMed] [Google Scholar]
  • 26.Kang SW, Ahn K, Ham DI. Types of macular hole closure and their clinical implications. Br J Ophthalmol. 2003;87: 1015–1019. doi: 10.1136/bjo.87.8.1015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. URL: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm [cited 2023 May 07]
  • 28.Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327: 557–560. doi: 10.1136/bmj.327.7414.557 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.DerSimonian R, Kacker R. Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials. 2007;28: 105–114. doi: 10.1016/j.cct.2006.04.004 [DOI] [PubMed] [Google Scholar]
  • 30.Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14: 135. doi: 10.1186/1471-2288-14-135 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Smiddy WE, Flynn HW Jr. Pathogenesis of macular holes and therapeutic implications. Am J Ophthalmol. 2004;137: 525–537. doi: 10.1016/j.ajo.2003.12.011 [DOI] [PubMed] [Google Scholar]
  • 32.Freeman WR, Azen SP, Kim JW, el-Haig W, Mishell DR 3rd, Bailey I. Vitrectomy for the treatment of full-thickness stage 3 or 4 macular holes. Results of a multicentered randomized clinical trial. The Vitrectomy for Treatment of Macular Hole Study Group. Arch Ophthalmol. 1997;115: 11–21. doi: 10.1001/archopht.1997.01100150013002 [DOI] [PubMed] [Google Scholar]
  • 33.Park DW, Sipperley JO, Sneed SR, Dugel PU, Jacobsen J. Macular hole surgery with internal-limiting membrane peeling and intravitreous air. Ophthalmology. 1999;106: 1392–1397. doi: 10.1016/S0161-6420(99)00730-7 [DOI] [PubMed] [Google Scholar]
  • 34.Pradhan D, Agarwal L, Joshi I, Kushwaha A, Aditya K, Kumari A. Internal limiting membrane peeling in macular hole surgery. Ger Med Sci. 2022;20: Doc07. doi: 10.3205/000309 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Kumagai K, Furukawa M, Ogino N, Uemura A, Demizu S, Larson E. Vitreous surgery with and without internal limiting membrane peeling for macular hole repair. Retina. 2004;24: 721–727. doi: 10.1097/00006982-200410000-00006 [DOI] [PubMed] [Google Scholar]
  • 36.Lee JE, Byon I, Park SW. Anatomy of Internal Limiting Membrane. In: Lee JE, Byon I, Park SW. editors. Internal Limiting Membrane Surgery. Singapore: Springer Nature Singapore; 2020. pp. 5–8. [Google Scholar]
  • 37.Mete M, Alfano A, Guerriero M, Prigione G, Sartore M, Polito A, et al. INVERTED INTERNAL LIMITING MEMBRANE FLAP TECHNIQUE VERSUS COMPLETE INTERNAL LIMITING MEMBRANE REMOVAL IN MYOPIC MACULAR HOLE SURGERY: A Comparative Study. Retina. 2017;37: 1923–1930. doi: 10.1097/IAE.0000000000001446 [DOI] [PubMed] [Google Scholar]
  • 38.Ch’ng SW, Patton N, Ahmed M, Ivanova T, Baumann C, Charles S, et al. The Manchester Large Macular Hole Study: Is it Time to Reclassify Large Macular Holes? Am J Ophthalmol. 2018;195: 36–42. doi: 10.1016/j.ajo.2018.07.027 [DOI] [PubMed] [Google Scholar]
  • 39.Manasa S, Kakkar P, Kumar A, Chandra P, Kumar V, Ravani R. Comparative Evaluation of Standard ILM Peel With Inverted ILM Flap Technique In Large Macular Holes: A Prospective, Randomized Study. Ophthalmic Surg Lasers Imaging Retina. 2018;49: 236–240. doi: 10.3928/23258160-20180329-04 [DOI] [PubMed] [Google Scholar]
  • 40.Chen G, Tzekov R, Jiang F, Mao S, Tong Y, Li W. Inverted ILM flap technique versus conventional ILM peeling for idiopathic large macular holes: A meta-analysis of randomized controlled trials. PLoS One. 2020;15: e0236431. doi: 10.1371/journal.pone.0236431 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Kase S, Saito W, Mori S, Saito M, Ando R, Dong Z, et al. Clinical and histological evaluation of large macular hole surgery using the inverted internal limiting membrane flap technique. Clin Ophthalmol. 2016;11: 9–14. doi: 10.2147/OPTH.S119762 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Shiode Y, Morizane Y, Matoba R, Hirano M, Doi S, Toshima S, et al. The Role of Inverted Internal Limiting Membrane Flap in Macular Hole Closure. Invest Ophthalmol Vis Sci. 2017;58: 4847–4855. doi: 10.1167/iovs.17-21756 [DOI] [PubMed] [Google Scholar]
  • 43.Kikushima W, Imai A, Toriyama Y, Hirano T, Murata T, Ishibashi T. Dynamics of macular hole closure in gas-filled eyes within 24 h of surgery observed with swept source optical coherence tomography. Ophthalmic Res. 2015;53: 48–54. doi: 10.1159/000368437 [DOI] [PubMed] [Google Scholar]
  • 44.Ullrich S, Haritoglou C, Gass C, Schaumberger M, Ulbig MW, Kampik A. Macular hole size as a prognostic factor in macular hole surgery. Br J Ophthalmol. 2002;86: 390–393. doi: 10.1136/bjo.86.4.390 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Jiro Kogo

14 Jan 2024

PONE-D-23-38847

Efficacy of inverted inner limiting membrane flap technique for macular holes of ≤400 µm: A systematic review and meta-analysis

PLOS ONE

Dear Dr. Byon,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we have decided that your manuscript does not meet our criteria for publication and must therefore be rejected.

I am sorry that we cannot be more positive on this occasion, but hope that you appreciate the reasons for this decision.

Kind regards,

Jiro Kogo

Academic Editor

PLOS ONE

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: I read the article “Efficacy of inverted inner limiting membrane flap technique for macular holes of ≤400 μm: A systematic review and meta-analysis” with interest. The article reviewed articles focusing on small and medium-sized macular holes and attempted to answer the question of whether an inverted internal limiting membrane flap is beneficial for these smaller holes. The authors concluded, after pooled analysis of four retrospective studies and two prospective studies, that either the ILM flap or the ILM peeling achieved a high anatomical success rate, and there were differences between the two. Several comments as below:

1. The main concern is whether the current evidence is powered enough to detect the minor difference, if any, in primary hole closure between ILM flap and ILM peeling. The retrospective studies have an inherent selection bias, and the two enrolled prospective randomized trials consisted of only 66 patients in total. The fact that the calculated P value between the ILM flap and ILM peeling technique on the primary hole closure rate was 0.09, which is approaching 0.05, is alarming.

2. If the current evidence is not sufficient, the conclusion should be stated as such or should state the limitations. The abstract should be revised accordingly.

3. There are different types of macular holes. I presume this study focused on full-thickness macular holes. This should be defined clearly.

4. The title could be revised to show the aim of the study, which was a comparison between ILM peeling and ILM flap.

5. “the primary outcome measure was anatomical hole closure rate” should clearly state whether it was the primary or the secondary hole closure.

6. The ILM flap technique has some variations and potentially affects the outcomes. This should be acknowledged in the discussion or as a limitation of this study.

Reviewer #2: Interesting and well written manuscript. I consider this paper fully suitable for publication on this journal. The topic is interesting. The results are clear. The English language is fluent. No further comments for the authors.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

- - - - -

For journal use only: PONEDEC3

PLoS One. 2024 Apr 29;19(4):e0302481. doi: 10.1371/journal.pone.0302481.r002

Author response to Decision Letter 0


10 Feb 2024

Dear Editor & Reviewers,

We appreciate all suggestions and corrections. All authors have carefully reviewed these comments. Our detailed responses to comments are addressed below.

Comments to the Author

Reviewer #1: I read the article “Efficacy of inverted inner limiting membrane flap technique for macular holes of ≤400 μm: A systematic review and meta-analysis” with interest. The article reviewed articles focusing on small and medium-sized macular holes and attempted to answer the question of whether an inverted internal limiting membrane flap is beneficial for these smaller holes. The authors concluded, after pooled analysis of four retrospective studies and two prospective studies, that either the ILM flap or the ILM peeling achieved a high anatomical success rate, and there were differences between the two. Several comments as below:

1. The main concern is whether the current evidence is powered enough to detect the minor difference, if any, in primary hole closure between ILM flap and ILM peeling. The retrospective studies have an inherent selection bias, and the two enrolled prospective randomized trials consisted of only 66 patients in total. The fact that the calculated P value between the ILM flap and ILM peeling technique on the primary hole closure rate was 0.09, which is approaching 0.05, is alarming.

2. If the current evidence is not sufficient, the conclusion should be stated as such or should state the limitations. The abstract should be revised accordingly.

Response 1-2: Among studies in this meta-analysis, about half of eyes were derived from the data of Baumann and colleagues’ study (the closure rates of the ILM flap and ILM peeling technique were 100% and 96%, respectively). It might impact on the overall results of our analysis. Therefore, we had excluded the data of Baumann et al. and analyzed two surgical techniques to clarify this. Additional data analysis showed that the closure rate of MH approached to 99% (109/110) in the inverted flap technique and 97% (111/115) in the ILM peeling technique, respectively (P = 0.45). This also showed no difference of two surgical techniques in the primary hole closure rate. As the reviewer pointed out, careful interpretation should be needed in comparison between the ILM flap and ILM peeling technique. The following phrase was added to limitation.

“Seventh, the P value of the difference of the two techniques in MH closure rate was 0.09, which tends to be close to a significant difference. The retrospective studies may have an inherent selection bias. About half of eyes were derived from the data of Baumann and colleagues’ study (the closure rates of the ILM flap and ILM peeling technique were 100% and 96%, respectively). These might impact on the overall results of our analysis. To clarify this, when excluding the data of Baumann et al., additional meta-analysis showed that the closure rate of MH approached to 99% (109/110) in the inverted flap technique and 97% (111/115) in the ILM peeling technique, respectively (P = 0.45). This also showed no difference of two surgical techniques in the primary hole closure rate. However, different outcomes may come out if more data can be achieved in future RCT studies” (in the page 20)

3. There are different types of macular holes. I presume this study focused on full-thickness macular holes. This should be defined clearly.

Response 3: The term first mentioned in the abstract was changed to “full-thickness macular hole”, and the inclusion criteria (page 4) of materials and methods was changed to “First, for population (participants), patients diagnosed with idiopathic full-thickness MH.”

4. The title could be revised to show the aim of the study, which was a comparison between ILM peeling and ILM flap.

Response 4: We don’t think that the title needs to be changed, regarding of word count (150) and aim of study for the efficacy of the inverted ILM flap technique in small FTMH.

5. “the primary outcome measure was anatomical hole closure rate” should clearly state whether it was the primary or the secondary hole closure.

Response 5: As the reviewer pointed out, the criteria for anatomical closure are specified in the following statement: “Third, for outcome measures, the primary outcome measure was anatomical hole closure rate in the first operation.” (in page 5, second paragraph)

6. The ILM flap technique has some variations and potentially affects the outcomes. This should be acknowledged in the discussion or as a limitation of this study.

Response 6: As the reviewer’s comments, the following phrases were added in the limitations: “Eighth, the surgeon’s factor of the inverted ILM flap technique can be more various than the ILM peeing technique and it may influence the outcomes.” (in the page 21)

Reviewer #2: Interesting and well written manuscript. I consider this paper fully suitable for publication on this journal. The topic is interesting. The results are clear. The English language is fluent. No further comments for the authors.

Response: Thank you.

Attachment

Submitted filename: Point-by-point response to the reviewers.docx

pone.0302481.s002.docx (16.5KB, docx)

Decision Letter 1

Koichi Nishitsuka

5 Apr 2024

Efficacy of inverted inner limiting membrane flap technique for macular holes of ≤400 µm: A systematic review and meta-analysis

PONE-D-23-38847R1

Dear Dr. Byon,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Koichi Nishitsuka

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: I thank the authors for revising the manuscript. All my concerns have been addressed. I have no further comments for this work.

Reviewer #2: The authors well addressed all the comments. No further comments. I encourage the publication of the manuscript

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Checklist. PRISMA 2009 checklist.

    (DOCX)

    pone.0302481.s001.docx (28.6KB, docx)
    Attachment

    Submitted filename: Point-by-point response to the reviewers.docx

    pone.0302481.s002.docx (16.5KB, docx)

    Data Availability Statement

    All relevant data are within the paper and its Supporting information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES